Dong Hui Yang
Founder at Hangzhou Adlai Nortye Biopharma Co. Ltd.
Profile
Dong Hui Yang was the founder of Hangzhou Adlai Nortye Biopharma Co. Ltd.
which was founded in 2004, where he held the title of Executive Director & Senior Vice President.
He also held the title of Executive Director & Senior Vice President at Adlai Nortye Ltd.
in a former job.
Mr. Yang received his graduate degree from South China Normal University in 2002 and his undergraduate degree from Jiangxi Normal University in 1999.
Dong Hui Yang active positions
| Companies | Position | Start |
|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Founder | 31/12/2003 |
Former positions of Dong Hui Yang
| Companies | Position | End |
|---|---|---|
| ADLAI NORTYE LTD. | Director/Board Member | - |
Training of Dong Hui Yang
| Jiangxi Normal University | Undergraduate Degree |
| South China Normal University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Private companies | 1 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Dong Hui Yang
